All -
We have corporate clients that are starting to request antimicrobials in response to Covid-19. I assume we are not the only ones seeing an increase in these requests. Knowing that the evidence supporting antimicrobials has limited to no efficacy, how are you approaching these conversations? We want to continue to advise based on science, and not on fear but in the current climate it is becoming increasingly difficult.
Stay healthy and sane, Allison